Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients

Clinical trial NCT05225077 · UNKNOWN

Trial details

NCT number: NCT05225077
Sponsor: Dong-A University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic Cardiac Catheterization Percutaneous Coronary Intervention

Start date: 2022-01-01
Primary completion: 2022-12-31
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.